C
Caroline Galeotti
Researcher at University of Paris-Sud
Publications - 74
Citations - 2728
Caroline Galeotti is an academic researcher from University of Paris-Sud. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 21, co-authored 63 publications receiving 1789 citations. Previous affiliations of Caroline Galeotti include French Institute of Health and Medical Research & Université Paris-Saclay.
Papers
More filters
Journal ArticleDOI
Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort.
Marie Pouletty,Charlotte Borocco,Naim Ouldali,Marion Caseris,Romain Basmaci,Noémie Lachaume,Philippe Bensaid,Samia Pichard,Hanane Kouider,Guillaume Morelle,Irina Craiu,Corinne Pondarré,Anna Deho,Arielle Maroni,Mehdi Oualha,Zahir Amoura,Julien Haroche,Juliette Chommeloux,Fanny Bajolle,Constance Beyler,Stéphane Bonacorsi,Guislaine Carcelain,Isabelle Koné-Paut,Brigitte Bader-Meunier,Albert Faye,Ulrich Meinzer,Caroline Galeotti,Isabelle Melki +27 more
TL;DR: Kawa-COVID-19 likely represents a new systemic inflammatory syndrome temporally associated with SARS-CoV-2 infection in children, and further prospective international studies are necessary to confirm these findings and better understand the pathophysiology of Kawa- CO VID-19.
Journal ArticleDOI
Autoimmune and inflammatory diseases following COVID-19.
TL;DR: Emerging reports show that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection precedes the appearance of various autoimmune and autoinflammatory diseases, including paediatric inflammatory multisystemic syndrome (PIMS) or mult isystem inflammatory syndrome in children (MIS-C), thus adding to the growing mystery of this virus.
Journal ArticleDOI
Recommendations for the management of autoinflammatory diseases
Nienke M. ter Haar,Marlen Oswald,Jerold Jeyaratnam,Jordi Anton,Karyl S. Barron,Paul A. Brogan,Luca Cantarini,Caroline Galeotti,Gilles Grateau,Véronique Hentgen,Michael Hofer,Tilmann Kallinich,Isabelle Koné-Paut,Helen J. Lachmann,Huri Ozdogan,Seza Ozen,Ricardo Russo,Anna Simon,Yosef Uziel,Carine Wouters,Brian M. Feldman,Sebastiaan J. Vastert,Nico M Wulffraat,Susanne M. Benseler,Joost Frenkel,Marco Gattorno,Jasmin B Kuemmerle-Deschner +26 more
TL;DR: These recommendations aim to optimise the management of patients with CAPS, TRAPS and MKD by developing evidence-based recommendations developed using the European League Against Rheumatism standard operating procedure.
Journal ArticleDOI
Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children.
Naim Ouldali,Julie Toubiana,Denise Antona,Etienne Javouhey,Fouad Madhi,Mathie Lorrot,Pierre-Louis Leger,Caroline Galeotti,Caroline Claude,Arnaud Wiedemann,Noémie Lachaume,Caroline Ovaert,Morgane Dumortier,Jean-Emmanuel Kahn,Alexis Mandelcwajg,Lucas Percheron,Blandine Biot,Jeanne Bordet,Marie-Laure Girardin,David D. Yang,Marion Grimaud,Mehdi Oualha,Slimane Allali,Fanny Bajolle,Constance Beyler,Ulrich Meinzer,Ulrich Meinzer,Michael Levy,Ana-Maria Paulet,Corinne Levy,Robert Cohen,Alexandre Belot,François Angoulvant +32 more
TL;DR: In this article, the authors compared intravenous immunoglobulins (IVIG) plus methylprednisolone vs IVIG alone as initial therapy in multisystem inflammatory syndrome in children (MIS-C).
Journal ArticleDOI
IVIG-mediated effector functions in autoimmune and inflammatory diseases
TL;DR: Experimental and clinical data provide an indicator that the therapeutic benefit of IVIG therapy is due to several mutually non-exclusive mechanisms affecting soluble mediators as well as cellular components of the immune system.